Skip to Content
Morningstar

Veeva Systems Inc Class A VEEV

Morningstar Rating
Unlock
Stock XNYS Rating as of
$203.78 −0.13 (0.06%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Veeva Face Mild Near-Term Services Headwinds ,but Our Long-Term Outlook Remains Strong

Keonhee Kim

Veeva is the leading provider of cloud-based software solutions tailored to the life sciences industry. It provides an ecosystem of products to address the operating challenges and regulatory requirements that companies in the space face. Instead of focusing on a general, one-size-fits-all system, Veeva has created platforms that are purely designed to serve one industry. And this vertical focus has allowed the company to shape its products for its specific customers to fit their specific needs. Veeva is deeply penetrated in its addressable market, and its continued expanding portfolio of applications presents itself as one of the most attractive offerings in the space.

Read Full Report

Price vs Fair Value

View History
VEEV is trading within a range we consider fairly valued.
Price
$203.78
Fair Value
$228.00
Uncertainty
High
1-Star Price
$937.80
5-Star Price
$521.00
Economic Moat
Xgqhx
Capital Allocation
Ptbrjfhn

Bulls Say, Bears Say

Bulls

Veeva Vault continues to implement new products to its suite, which makes the offering even more attractive.

Bears

Moving its CRM from Salesforce’s platform to its Vault Platform could raise concerns for customers and lower its retention rate.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VEEV is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$203.91
Day Range
$202.25–205.26
52-Week Range
$160.21–236.90
Bid/Ask
$200.00 / $203.78
Market Cap
$32.93 Bil
Volume/Avg
541,920 / 920,857

Key Statistics

Price/Earnings (Normalized)
42.13
Price/Sales
14.10
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Mid Growth
Total Number of Employees
7,172
Website
https://www.veeva.com

Competitors

Valuation

View More
Metric
VEEV
IQV
CRM
Price/Earnings (Normalized)
 42.1322.7333.64
Price/Book Value
 7.086.724.51
Price/Sales
 14.102.887.82
Price/Cash Flow
 39.2018.2620.85
Price/Earnings
VEEV
IQV
CRM

Financial Strength

Metric
VEEV
IQV
CRM
Quick Ratio
 4.170.760.96
Current Ratio
 4.240.861.09
Interest Coverage
 —3.1218.87
Quick Ratio
VEEV
IQV
CRM

Profitability

Metric
VEEV
IQV
CRM
Return on Assets (Normalized)
 15.10%7.28%8.50%
Return on Equity (Normalized)
 18.98%31.85%13.87%
Return on Invested Capital (Normalized)
 15.89%12.78%11.66%
Return on Assets
VEEV
IQV
CRM
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Health Information Services Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common Stock—Qkxpy$38.1 Bil
SOLV
Solventum Corp—Nsqync$11.2 Bil
PMCUF
Pro Medicus Ltd—Cmpzjg$8.0 Bil
MTHRF
M3 Inc—Btjds$7.4 Bil
MTHRY
M3 Inc ADR—Ygkwpw$7.4 Bil
HQY
HealthEquity Inc—Nyqmcg$6.7 Bil
RCM
R1 RCM Inc—Jwvg$5.1 Bil
DOCS
Doximity Inc Class A—Gwhqbk$4.4 Bil
TXG
10x Genomics Inc Ordinary Shares - Class A—Vbmg$3.2 Bil

Sponsor Center